Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Today sector : Health technology crawled time : 11:00 save search
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
TFX | News | $207.38 -0.44% 0.0% 150K
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
first conference
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
AGIO | News | $29.43 1.38% 1.36% 550K
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
first conference financial results
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
SWTX | News | $42.48 -3.7% -3.84% 810K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
first report therapeutics financial results
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
SNN | News | $24.01 0.38% 0.0% 1.4M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
|
| O: 10.02%
H: 0.0%
C: 0.0%
million biopharma
Todays' Top-5
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
BPTH | News 0 d | $4.26 31.48% 23.94% 83M
|
Health Technology
|
| O: 73.48%
H: 0.0%
C: 0.0%
bp1002 leukemia trial
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
OCUL | News | $5.86 -22.69% -29.35% 6.1M
|
Health Technology
|
| O: -5.78%
H: 0.0%
C: 0.0%
ocular positive for topline diabetic
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
TLSA | News | $0.6199 20.84% 17.24% 1.5M
|
Health Technology
|
| O: 5.05%
H: 0.0%
C: 0.0%
life neurology foralumab sciences meeting imaging
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cd20 briumvi contract sclerosis for therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.